glutathione kills triple negative cancer depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast Targeting the redox-programmed cell death
Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Frontiers Patterns of immune evasion in triple negative breast cancer and new potential therapeutic targets: a review Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC Application of glutathione depletion in cancer therapy: Enhanced ROS based therapy, ferroptosis, and chemotherapy ScienceDirect Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Frontiers Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13





